## MAR: Marriott International, Inc. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_20 3.1% below STRENGTH zone (4.0-10.0%); PEG 1.70 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: declining volume (47% of avg).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($303.40)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 8
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. IHG, Club Chaulani sign management deal for Holiday Inn Dhangadhi in Nepal**
- Source: Hotel Management Network | 20251224T130911 | Somewhat-Bullish | Relevance: 100%
- IHG Hotels & Resorts and Club Chaulani have signed a management agreement for a Holiday Inn property in Dhangadhi, Nepal, marking IHG’s debut in Sudurpashchim Province. The 115-room hotel is slated to open in Q1 2028 and will cater to business, government, transit, and leisure travellers due to its strategic location and planned amenities. This venture supports IHG’s strategy to expand in high-potential, under-served South Asian markets.

**2. Your complete guide to travel protections on American Express cards**
- Source: The Points Guy | 20251224T150723 | Somewhat-Bullish | Relevance: 74%
- This guide details the various travel protections offered by American Express cards, covering aspects like trip delay insurance, trip cancellation and interruption insurance, Global Assist Hotline services, baggage insurance, and car rental loss and damage insurance. It categorizes cards into "higher-end" and "mid-tier" levels for each protection type, specifying coverage limits and applicable terms. The article aims to help cardholders understand and utilize the travel benefits associated with their American Express cards.

**3. Chatham Lodging Trust Announces Sale of Massachusetts Hotel**
- Source: LODGING Magazine | 20251226T140852 | Neutral | Relevance: 64%
- Chatham Lodging Trust sold its 147-suite Homewood Suites by Hilton in Billerica, Massachusetts, for $17.4 million. A planned $6 million renovation for 2025 was not completed due to the sale. This transaction is the sixth hotel sold by the trust since December 2024, bringing total proceeds to approximately $100 million.

**4. LogProstyle Expands Hotel Portfolio In Tokyo As Tourism Growth Continues**
- Source: Travel And Tour World | 20251224T050951 | Somewhat-Bullish | Relevance: 62%
- LogProstyle Inc. reported its fiscal results for the first half of FY2026, showcasing strong growth in its hospitality division despite a modest overall revenue decline. The company's hotel revenue increased by 10.7%, driven by higher occupancy rates and average daily rates, fueled by Japan's booming inbound tourism. LogProstyle is expanding its hotel portfolio, with a new property in Tokyo's Asakusa district slated to open in 2028, underscoring its commitment to sustainable growth in the Japanese tourism market.

**5. Clinic, IHG to upgrade hotel to voco Suites**
- Source: NEO-Trans.blog | 20251224T120911 | Somewhat-Bullish | Relevance: 61%
- The InterContinental Suites Hotel Cleveland at Cleveland Clinic is set for a significant upgrade to voco Suites, a global brand by IHG Hotels & Resorts offering resort-style amenities. A joint $1.24 million investment by property owner Cleveland Clinic and IHG will transform the 162-room hotel's common spaces, restaurant-bar, and guest rooms, with completion expected by October 2026. This conversion leverages voco Suites' rapid expansion strategy through existing hotel upgrades, aiming to provide an enhanced experience for guests, particularly those undergoing extended medical treatments.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Barclays | $276 | $274 | +1% |
| 2025-12-15 | Goldman Sachs | $345 | $288 | +20% |
| 2025-12-04 | Truist Securiti | $283 | $278 | +2% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Barclays | main | Equal-Weight |
| 2025-12-15 | Goldman Sachs | up | Buy |
| 2025-12-04 | Truist Securiti | main | Hold |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 4 ($0.00M) |
| Sells | 14 ($27.11M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 35.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 7.7% (+1.1%)
- Blackrock Inc.: 5.7% (+0.3%)
- JPMORGAN CHASE & CO: 5.0% (+40.6%)
- State Street Corpora: 3.5% (-0.3%)
- Wellington Managemen: 3.4% (+21.7%)

### Key Risks

1. Volume divergence: price rising (+0.2% MRS) on declining volume (47% of avg) suggests distribution.
2. Heavy insider selling: $27M sold (14 transactions in 90 days).
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Analyst target momentum: 3 raises (avg +7%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.70 elevated, pricing in significant growth expectations. Forward P/E 27.7x stretched relative to 12% growth. Quality metrics strong (margin 38%). Analyst sentiment positive (3 raises, avg +7%). Insider selling cluster ($27.1M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $85.7B |
| Beta | 1.16 |
| 52W Range | $205.40 - $316.69 |
| Short Interest | 3.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.70 |
| Forward P/E | 27.7 |
| Current P/E | 31.2 |
| YoY Growth | 12.5% |
| EPS Direction | STABLE |

### Technicals

MRS_20 stable at 3.1% (minimal 5-day change). Below STRENGTH zone by 0.9pp (needs >4.0% for momentum thesis). MRS_5 at 0.2% confirms short-term momentum alignment. AM_20 at 4.1% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.93), confirming momentum. Volume at 47% of 20MA suggests lack of conviction. OFD pattern: +SLL (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 3.14% (CS: 85) | Neutral |
| RSI_14 | 67.2 | Neutral |
| MACD Histogram | 0.93 | Bullish |
| vs SMA20 | 1.041x | Above |
| vs SMA50 | 1.094x | Above |
| vs SMA200 | 1.186x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $315.58
- **Stop Loss:** $303.40 (3.9% risk)
- **Target:** $327.76 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 67
- **Position Value:** $21,143.86
- **Portfolio %:** 21.14%
- **Risk Dollars:** $825.00
- **Risk Per Trade:** 0.83%
- **Modifiers:** L1 110% | L2 75% | Combined 0.83x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.10x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with selective risk appetite amid holiday trading. VIX at extreme lows (13.6) signals complacency while positive yield curve (+59bps) and stable economic data support continuation. Focus on quality names with AI/infrastructure exposure while monitoring January volatility reset.*

### Earnings

**Next:** 2026-02-10 (Est: $2.61)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.39 | $2.47 | +3.5% |
| 2025Q2 | $2.62 | $2.65 | +1.1% |
| 2025Q1 | $2.25 | $2.32 | +3.0% |
| 2024Q4 | $2.38 | $2.45 | +2.7% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*